HomeNewsWorldVirgin Australia collapses; enters voluntary administration after being hit by coronavirus crisis

Virgin Australia collapses; enters voluntary administration after being hit by coronavirus crisis

The move came after the airline, which suspended almost all flights last month following wide-spread travel bans, failed to secure A$1.4 billion (USD 887.60 million) loan from the federal government.

April 21, 2020 / 15:13 IST
Story continues below Advertisement

Australia's second biggest airline, Virgin Australia, collapsed on Tuesday, putting 16,000 jobs under threat as the cash-strapped carrier announced that it entered voluntary administration to recapitalise the business after being battered by the coronavirus pandemic, which has crippled the global airline industry.

The move came after the airline, which suspended almost all flights last month following wide-spread travel bans, failed to secure A$1.4 billion (USD 887.60 million) loan from the federal government.

Story continues below Advertisement

In a statement, Virgin Australia said the group has entered into voluntary administration to “recapitalise the business and help ensure it emerges in a strong financial position on the other side of the COVID-19 crisis”.

The group's board of directors has appointed accounting firm Deloitte as voluntary administrators.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show